Gene Therapy

Researchers at University of Navarra, Gene Therapy Center Target Gene Therapy

Published in Vaccine Weekly, February 2nd, 2011

2011 FEB 2 -- "Infection with HBV and HCV are considered the most important etiological factors for hepatocellular carcinoma (HCC). Current treatment options are insufficient, creating an urgent need for new therapeutic strategies that inhibit disease progression and improve survival in patients with HCC," scientists in Pamplona, Spain report.

"A promising strategy for the treatment of HCC is gene therapy (GT), which is characterized by the transduction of tumor cells with genes displaying antitumor properties, such as pro-apoptotic, suicide, anti-angiogenic and immunomodulatory genes, as well as siRNAs. Other GT strategies have investigated oncolytic viral...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2011-02-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry